Here’s What To Look For Ahead Of The Myokardia Inc (MYOK) Phase II

Myokardia Inc (NASDAQ:MYOK) just announced topline from its lead cardiovascular trial, and alongside the data, reported it intends to carry the drug under investigation into a...

Keep Reading →